
Catalys Pacific Launches Kirilys Therapeutics as a Multi-asset Precision Oncology Company
Kirilys Therapeutics, Inc., a private, preclinical-stage biopharmaceutical company founded by investment firm Catalys Pacific, announced today that the Company completed a seed financing led by Lightspeed Venture Partners.